Nodexon

Medicinal product

(Invented) name

Nodexon

Active substance (s)

Deksametazonas

Strength

8 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H02AB02, Dexamethasone

Marketing authorisation holder

UAB Norameda, Lietuva

Date of authorisation

2021-06-02

Date of renewal

Documents

4756_4757 Pakuotės lapelis 4mg, 8mg 2022 10 28.docx

4756_4757 Nodexon 4mg,8mg tab PCS PL 2022 10 28.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

PL/H/0688/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Deksametazonas	8 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106615	92717	1092717	lizdinė plokštelė	N20		Receptinis	LT/1/21/4757/001	Tiekiama	-	-	No	-	-
106616	92718	1092718	lizdinė plokštelė	N30		Receptinis	LT/1/21/4757/002	Netiekiama	-	-	No	-	-
106617	92719	1092719	lizdinė plokštelė	N50		Receptinis	LT/1/21/4757/003	Netiekiama	-	-	No	-	-
106618	92720	1092720	lizdinė plokštelė	N100		Receptinis	LT/1/21/4757/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-06-02	Registruotas